Physician profile
Christopher Donald Valkier
NPI 1639699408
$9,887.58
in general payments reported to CMS, 2019-2025
15 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,901 · 2020: $265 · 2021: $346 · 2022: $379 · 2023: $249 · 2024: $2,147 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Travel and Lodging: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.87 |
| Travel and Lodging | $1,124.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,016.05 | 2019 | |
| Stryker Corporation | $3,707.94 | 2019-2025 | Infinity, Inbone, Variax |
| Treace Medical Concepts, INC. | $608.80 | 2023-2025 | |
| Osteomed LLC | $544.94 | 2019-2022 | |
| Smith+Nephew, INC. | $253.01 | 2021-2025 | Grafix Pl, Collagenase Santyl, Grafix |
| Depuy Synthes Sales INC. | $184.37 | 2019-2022 | |
| Pinnacle, INC | $133.13 | 2019-2020 | |
| Bioventus LLC | $127.62 | 2019-2022 | |
| Cardiovascular Systems INC. | $77.94 | 2019 | |
| Integra Lifesciences Corporation | $71.19 | 2019 | |
| Paragon 28, INC. | $63.93 | 2022-2023 | Ttc Nail |
| Wright Medical Technology, INC. | $31.38 | 2019 | |
| Nevro Corp. | $26.45 | 2022 | |
| Medline Industries LP | $22.62 | 2021 | |
| Biocomposites INC | $18.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Valkier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.